Granules India Limited — Updates, 11-11-2025: Press Release
11-11-2025 | 11:18 am
11-11-2025 | 11:18 am
Granules' subsidiary, Granules Life Sciences, secured its first U.S. FDA approval for its Hyderabad facility. This expands finished dosage manufacturing, enabling a new product launch in the U.S. to boost market share and ensure business continuity.
No comments yet. Be the first to comment!
